Hemostatic Role of a Folkloric Medicinal Plant Extract in a Rat Partial Nephrectomy Model: Controlled Experimental Trial

被引:49
作者
Huri, Emre [1 ]
Akguel, Turgay [1 ]
Ayyildiz, Ali [1 ]
Uestuen, Hueseyin [2 ]
Germiyanoglu, Cankon [1 ]
机构
[1] Ankara Numune Training & Res Hosp, Urol Clin 2, Ankara, Turkey
[2] Ankara Numune Training & Res Hosp, Dept Pathol, Ankara, Turkey
关键词
kidney; rats; Wistar; nephrectomy; hemorrhage; hemostasis; LAPAROSCOPIC PARTIAL NEPHRECTOMY; NEPHRON-SPARING SURGERY; ANKAFERD BLOOD STOPPER; RENAL TUMORS; SEALANT; OCCLUSION; OUTCOMES; AGENT; GLUES;
D O I
10.1016/j.juro.2009.01.016
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Ankaferd BloodStopper (R) is a mixture of 5 plants used in traditional Turkish medicine as hemostatic agent for external traumatic, postoperative and dental bleeding. We investigated the hemostatic efficacy of Ankaferd BloodStopper for partial nephrectomy. Materials and Methods: A total of 24 Wistar rats were divided into 4 groups of 6 each. Group I underwent partial nephrectomy with hilar control as the conventional technique. Group 2 underwent the conventional technique with hemostatic agent application. Group 3 underwent hemostatic agent application to the renal parenchyma. In Group 4 partial nephrectomy was performed and the hemostatic agent was used without hilar control. Warm ischemia and partial nephrectomy times, and the number of hemostatic agent applications were recorded. Histopathological evaluations were completed. The Fisher, Kruskal-Wallis and Mann-Whitney U tests were used for statistical analysis. Results: Mean kidney size was 2 x 2.5 x 0.05 cm. Mean partial nephrectomy time was 3.7, 2.7, 1.8 and 3.2 minutes in groups 1 to 4, respectively, which was significantly different between groups 1 and 3 (p = 0.007). Warm ischemia time in group 3 was less than in group 1 (p = 0.011). The number of hemostatic agent applications was higher in groups 3 and 4 compared to those in group 2 (p = 0.003). Glomerular necrosis was detected at a higher rate in group 1 compared to that in groups 3 and 4 (p = 0.015). Calcification formed significantly more in group 1 than in groups 2 to 4 (p <0.05). Erythrocyte aggregation was greater in groups 2 to 4 than in group 1 (p = 0.015). Giant cell reaction, fibrosis, inflammation and microvascular proliferation were not statistically different among the groups (p >0.05). Conclusions: Ankaferd BloodStopper decreases partial nephrectomy and warm ischemia times, and provides hemostasis. Erythrocyte aggregation confirmed the hemostatic action of the agent, while the absence of glomerular necrosis and calcification may have positive relevance.
引用
收藏
页码:2349 / 2354
页数:6
相关论文
共 20 条
[1]  
Akkoc N, 2008, INT J LAB HEMATOL, V30, P95
[2]   Minimally invasive nephron-sparing surgery (MINSS) for renal tumours - Part I: Laparoscopic partial nephrectomy [J].
Aron, Monish ;
Gill, Inderbir S. .
EUROPEAN UROLOGY, 2007, 51 (02) :337-347
[3]  
BERGEL S, 1909, DEUT MED WOCHENSCHR, V35, P633
[4]   COMPLICATIONS OF NEPHRON SPARING SURGERY FOR RENAL TUMORS [J].
CAMPBELL, SC ;
NOVICK, AC ;
STREEM, SB ;
KLEIN, E ;
LICHT, M .
JOURNAL OF UROLOGY, 1994, 151 (05) :1177-1180
[5]   Hand-assisted laparoscopic partial nephrectomy in the porcine model using gelatin matrix hemostatic sealant without hilar occlusion [J].
Desai, PJ ;
Maynes, LJ ;
Zuppan, C ;
Berger, KA ;
Torrey, R ;
Baldwin, DD .
JOURNAL OF ENDOUROLOGY, 2005, 19 (05) :566-569
[6]  
Dogan OF, 2008, EUR J CLIN INVEST, V38, P341
[7]  
DONALDSON A, 2002, J ENDOUROL, V16, pA20
[8]   Improved hemostasis during laparoscopic partial nephrectomy using gelatin matrix thrombin sealant [J].
Gill, IS ;
Ramani, AP ;
Spaliviero, M ;
Xu, M ;
Finelli, A ;
Kaouk, JH ;
Desai, MM .
UROLOGY, 2005, 65 (03) :463-466
[9]   Laparoscopic partial nephrectomy for renal tumor: Duplicating open surgical techniques [J].
Gill, IS ;
Desai, MM ;
Kaouk, JH ;
Meraney, AM ;
Murphy, DP ;
Sung, GT ;
Novick, AC .
JOURNAL OF UROLOGY, 2002, 167 (02) :469-475
[10]   Haemostatic actions of the folkloric medicinal plant extract ankaferd blood Stopper® [J].
Goker, H. ;
Haznedaroglu, I. C. ;
Ercetin, S. ;
Kirazli, S. ;
Akman, U. ;
Ozturk, Y. ;
Firat, H. C. .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2008, 36 (01) :163-170